Alzai Health Corp. develops an AI-driven risk assessment tool for Alzheimer's Disease that operates non-invasively using existing patient data. The company focuses on early identification of individuals at risk or in the early stages of the disease, facilitating timely diagnosis, treatment, and preventive care. Alzai's solution integrates seamlessly with electronic medical records systems, making it accessible for healthcare providers. The company serves healthcare institutions and professionals involved in patient care and cognitive health.
- Website
- alzaihealth.com
- Issuer profile
- All listings